JUser: :_load: Unable to load user with ID: 89

Monday, 25 May 2015 17:33

18th Vicenza Course on Peritoneal Dialysis

Rate this item
(1 Vote)

vicenza course


18th Vicenza Course on Peritoneal Dialysis

Session 1: The Fundamentals of PD

  • Comparing PD to Hemodialysis: similarities and diversities - C.Ronco
  • Fundamentals of peritoneal membrane transport - B. Rippe
  • Peritoneal ultrafiltration: physiology and failure - M. Flessner
  • Long term changes in solute transport - S. Davies
  • Long term changes in fluid transport - A. Coester
  • The rationale for different PD schedules - J. Burkart

Session 2: The Vicenza PD Course

  • The Vicenza PD course from origin to today - C.Ronco
  • The impact of the Vicenza Course on education in PD worldwide - D. Oreopoulos

Session 3: Biology of peritoneal membrane

  • PD: a biological membrane with a non biological fluid - A.Jörres
  • Mechanism of mesothelial apoptosis in relation with PD fluids - C.Ronco on behalf of L. Gotloib
  • Different aspects of peritoneal damage: fibrosis and sclerosis - G.Garosi
  • Biological markers in the PD effluent: are they useful? - R.Krediet
  • Lights and shadows of the "Three pore model" - B.Rippe

Session 4: Peritoneal dialysis solutions

  • Peritoneal Angiogenesis in response to dialysis fluid - B.Rippe
  • Towards the ideal Peritoneal dialysis solution - W. Van Biesen
  • Tailoring PD fluid for optimal acid base targets - M. Feriani
  • Agents that modulate Peritoneal Membrane structure and function - C.Ronco on behalf of L.Gotloib
  • How to assess peritoneal transport: Which test should we use? - O. Heimbürger

Session 5: Clinical aspects of dialysis: Cardiovascular

  • Blood pressure regulation in PD Patients - F. Finkelstein
  • Dry body weight and ultrafiltration targets in peritoneal dialysis - R. Krediet
  • Acute hemodynamic effects of PD exchange - W. Van Biesen
  • Cardiovascular complications in PD patients - B. Piraino
  • Brain Natriuretic Peptide in PD Patients - M. Haapio
  • Pertioneal dialysis in patients with congestive heart failure - J. Burkart

Session 6: Inflammation and nutrition

  • Metabolic consequences of peritoneal dialysis treatment - R. Pecoits Filho
  • The role of nutritional status in the outcome of PD patients - R. De Mutsert
  • Erythropoietin in peritoneal dialysis: how to optimize therapy? - G.Brunori
  • Inflammation in PD: Mechanisms, biomarkers and effects on outcomes - O. Heimbürger on behalf of P.Stenvinkel

Session 7: Adequacy in PD: Kt/V and beyond

  • Is there a holistic concept for adequacy? - C.Ronco
  • How should we measure adequacy in the clinic - O.Heimbürger
  • How can we cope with guidelines? - R. Amerling
  • PD Adequacy: not just small solute clearance - I. Teitalbaum
  • Importance of residual renal function and PD in anuric patients - A. Rodrigues
  • Health-related quality of life in PD patients - F.Finkelstein

Session 8: Complications of PD and their Management

  • Peritoneal dialysis-related infections recommendations - B.Piraino
  • New treatment options and protocols for PD-related peritonitis - I.Teitelbaum
  • Lipid disorders, Statins and the PD membrane - O.Heimbürger
  • Complications of the peritoneal access and their mangement - M.Riella

Session 9: Calcium Phosphorus, VDR and PD

  • Calcium-Phosphorus metabolism in PD patients - F.Finkelstein
  • The physiology of Vit. D Receptor activation - J.Valdivielso
  • The importance of VDRs activation in clinical practice - M. Cozzolino
  • New Acquisition in the therapy of SHPT in CKD and PD patients - D.Brancaccio

Session 10: PD as a first choice treatment: advantages and barriers

  • PD survey results - N.Lameire
  • Result from dialysis opinion survey system - I.Ledebo
  • Barriers to the implementation of a PD Program - F.Martino
  • How to persuade PD - skeptical hemodialysis fans - A.Rodrigues
  • How to make PD affordable in developing countries - G.Abraham
  • PD before transplantation and after transplant failure - T.Lobbedez

Session 11: Peritoneal dialysis in special settings

  • Decision making around dialysis options - A.Mooney
  • PD in the unplanned start patient- J.Povlsen
  • Peritoneal dialysis in the elderly - E.Brown
  • Peritoneal dialysis in developing countries - Ks Nayak
  • Peritoneal dialysis dialysis in Acute Kidney Injury - C Y Chionh
  • Cost benefits of PD in specific patients groups - A.Rodrigues

Session 12: The present and future of Peritoneal Dialysis

  • CAPD and APD: are there differences in outcome? - R.Dell'aquila
  • The wearable artificial kidney: is PD the solution? - C.Ronco
  • What will be the role of industry in the future? - P.Rutherford
  • The Role of ISPD in the future of PD - S. Davies
  • Long term changes in fluid transport - W.K. Lo
  • Where is PD going in the next ten years - J. Burkart

Additional Info

  • Language: English
  • Contains Audio: Yes
  • Content Type: eLearning modules
  • Source: Other sources
  • Event: Other events
  • Year: 2015
  • Members Only: No
Read 3992 times Last modified on Thursday, 04 June 2015 22:06

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact


Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact